Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $175.16 million. The enterprise value is $93.53 million.

Market Cap	175.16M
Enterprise Value	93.53M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

TRVI has 68.96 million shares outstanding. The number of shares has increased by 53.44% in one year.

Shares Outstanding	68.96M
Shares Change (YoY)	+53.44%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	80.77%
Float	39.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.12
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.03, with a Debt / Equity ratio of 0.02.

Current Ratio	15.03
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-73.42

Financial Efficiency

Return on equity (ROE) is -31.50% and return on invested capital (ROIC) is -40.44%.

Return on Equity (ROE)	-31.50%
Return on Assets (ROA)	-28.90%
Return on Capital (ROIC)	-40.44%
Revenue Per Employee	n/a
Profits Per Employee	-$1.16M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-32,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.31% in the last 52 weeks. The beta is 0.87, so TRVI's price volatility has been lower than the market average.

Beta (1Y)	0.87
52-Week Price Change	-13.31%
50-Day Moving Average	2.97
200-Day Moving Average	2.08
Relative Strength Index (RSI)	38.83
Average Volume (30 Days)	306,317

Short Selling Information

The latest short interest is 898,412, so 1.30% of the outstanding shares have been sold short.

Short Interest	898,412
Short Previous Month	1.04M
Short % of Shares Out	1.30%
Short % of Float	2.29%
Short Ratio (days to cover)	2.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.92M
Pretax Income	-29.10M
Net Income	-29.07M
EBITDA	-28.58M
EBIT	-28.71M
Earnings Per Share (EPS)	-$0.29

Full Income Statement

Balance Sheet

The company has $82.97 million in cash and $1.34 million in debt, giving a net cash position of $81.63 million or $1.18 per share.

Cash & Cash Equivalents	82.97M
Total Debt	1.34M
Net Cash	81.63M
Net Cash Per Share	$1.18
Equity / Book Value	82.55M
Book Value Per Share	1.20
Working Capital	81.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.71 million and capital expenditures -$137,000, giving a free cash flow of -$31.85 million.

Operating Cash Flow	-31.71M
Capital Expenditures	-137,000
Free Cash Flow	-31.85M
FCF Per Share	-$0.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.44%
Shareholder Yield	-53.44%
Earnings Yield	-16.59%
FCF Yield	-18.18%

Analyst Forecast

The average price target for TRVI is $8.50, which is 234.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	234.65%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2